Speakers

2025 Speakers

Take a look at the 2025 speaker faculty for the 15th World Clinical Biomarkers & CDx Summit.

CB & CDx Ambassadors

Payers, Notified Bodies, & Patient Advocates

Pharmaceutical Leaders

Innovative Biotech

Research & Healthcare Institutes

Diagnostic & Solution Providers

CB & CDx Ambassadors

Mark Gustavson

Senior Director & Head, Computational Pathology Strategic Partnerships
AstraZeneca

Geoff Oxnard

Chief Medical Officer
BlossomHill Therapeutics

Sarah Hersey

Vice President - Precision Medicine
Bristol Myers Squibb

Ben Withey

Director of CDx
Pfizer

Brian Lockhart

Global Head of Companion Diagnostics
Servier

Payers, Notified Bodies, & Patient Advocates

Kevin Liang

Vice President, Optum Evidence Engine
Optum Life Sciences

Gabriel Bien-Willner

Chief Medical Officer
Palmetto GBA

Anthony Kanavage

IVD Product Assessment Team Manager
TÜV SÜD

Sally Werner

Chief Executive Officer
Cancer Support Community

Anna Berkenblit

Chief Scientific & Medical Officer
Pancreatic Cancer Action Network

Amin Farhoomand

Vice President of Strategy & Innovation, Data & Clinical Services
Optum Life Sciences

Pharmaceutical Leaders

Christine Ward

Industry Expert

Archana Simmons

Head of CDx and biomarkers
Abbvie

Dishant Kalra

Head of Precision Medicine
Astellas Pharma

Stefanie Meyer

Associate Director, Translational Medicine Lead
AstraZeneca

Andrea Renninger

Senior Director Regulatory Affairs, CDx
Daiichi Sankyo

Kazuishi Kubota

Head of Functional Excellence & Clinical Biomarker Oncology Dept
Daiichi Sankyo

SATYA SAXENA

Head, Global Proteomics, Translational Sciences
Eisai Co., Ltd.

Ying Wu

Director & Head of Human Genetics
Eisai Co., Ltd.

Susanne Rhoades

Associate Vice President, Diagnostic Development
Eli Lilly

Kathie Goodwin

Senior Director, Diagnostic Development
Eli Lilly & Co.

DUN LIANG

CDx reg strategy
Eli Lilly & Co.

Zheng Feng

Head of Clinical Genomics
EMD Serono, An affiliate of Merck KGaA, Darmstadt, Germany

Anupam Talapatra

Director
Gilead Sciences

Tom Battersby

Executive Director, Biomarker-Research
Gilead Sciences

Andrea Belanger

Director, Precision Diagnostics Partnering
GlaxoSmithKline

Cecilia Schott

Vice President, Head Precision Medicine Portfolio Planning
GSK

Nicole St Jean

Head, External Innovation
GSK

Florence Meyer-Losic

Vice President, Translational Sciences
Ipsen Pharma

Gabriele Allegri

VP Precision Medicine
Johnson & Johnson

Kristine Garside

Director, Digital Health, Global Commercial Strategy Organization
Johnson & Johnson

David Weingeist

Director, Leader - Scientific & Oncology Diagnostics
Johnson & Johnson

Guneet Walia

Senior Director - Data Science & Digital Health
Johnson & Johnson Innovative Medicine.

Renee Yura

Executive Director, Clinical Biomarkers
Moderna

Irina Leaf

Director - Therapeutic Area Biomarker Lead, Disease Area X and Global Health
Novartis AG

Samantha Carpenter

Senior Manager, Clinical Diagnostics
Pfizer

Shelley des Etages- Wong

Sr Director
Pfizer

Brian Baker

Executive Director - Regulatory Affairs In Vitro Diagnostics
Regeneron Pharmaceuticals

Jennifer Hamilton

Vice President & Head of Precision Medicine
Regeneron Pharmaceuticals

Jai Pandey

Jai Pandey, GRA Device Head, Diagnostics & Digital Health
Sanofi

Gerard Sanderink

Vice President & Global Head Laboratory Sciences
Sanofi

Cheng Yang

Digital Diagnostics Lead
Takeda Pharmaceutical

Innovative Biotech

Banu Sankaran

Head of Diagnostics Strategy & Development
Alexion Pharmaceuticals

June Lu

Chief Scientific Officer
BeyondSpring Pharmaceuticals Inc.

Jay Foust

Vice President, Companion Diagnostics & Precision Medicine Mythic Therapeutics Independent Board Director
BioAI Health

John Rossi

Vice President, Head of Translational Medicine
Capstan Therapeutics

Michelle Kinder

Director
Incyte Corporation

Mike Kagey

Vice President - Translational Medicine
Leap Therapeutics

Zhen Su

Chief Executive Officer
Marengo Therapeutics

Jorge DiMartino

Chief Medical Officer & Executive Vice President - Clinical & Translational Development
Plexium Inc.

Bill Keating

Chief Commercial Officer - Diagnostics & Healthcare
PrecisionLife Ltd.

Brenton Mar

Chief Medical Officer
Relay Therapeutics

Research & Healthcare Institutes

Sylvan Baca

Assistant Professor, Harvard Medical School & Medical Oncologist
Dana-Farber Cancer Institute

Mark Stewart

Vice President, Science Policy
Friends of Cancer Research

Pedram Razavi

oncologist
Memorial Sloan Kettering Cancer Center

Anil Parwani

Professor & Chair of the Department of Pathology
Ohio State University

Viktor Adalsteinsson

Director, Gerstner Center for Cancer Diagnostics
The Broad Institute of MIT & Harvard

Diagnostic & Solution Providers

Alan Arnold

Scientific Director Precision Medicine, Diagnostic Development Services
LabCorp

Alexander Kuklin

Vice President, BioPharma Partnerships
Predicine

Ali Kuraishy

Head, CDx Business Development
Illumina, Inc.

Bryant Wojcik

Sr Project and Alliance Manager
Abbott

Cecilia Fortugno

Vice President & Chief Operations Officer
Randox

Cecilia Villafan

Senior Clinical Project Manager
Abbott

Chris Van Haag

Senior Director - Global Strategic Partnerships
Biocartis

Christophe Homer

Director of Intelligence
Hanson Wade Intelligence

Colin McDowell

Senior Manager - Business Development
Biodesix

David Ribeiro

Chief Operating Officer
ARC Regulatory

Douglas Clark

Chief pathologist
Agilent Technologies

Eric Fung

Senior Vice President, Clinical Development, Population Health & Biostatistics
GRAIL

Eric Matthews

Senior Vice President, Chief Business Officer
Caris Life Sciences

Gary Potikyan

Chief Science Officer
EntroGen - Inc

Gulfem Guler

Vice President, Translational Research
Clear Note Health

J. Carl Barrett

Chief Scientific Officer
Precede Biosciences

Jean-Francois Martini

Senior Director, BioPharma Translational Strategy & Applications
Guardant Health

Jill Haizlip

Global Head of Regulatory Affairs
IQVIA Laboratories

John Simmons

Global Vice President, Biopharma & Oncology Partnerships
Natera

Karina Kulangara

Associate Vice President, CDx R&D
Agilent Technologies

Katarina Wikstrom

Global Vice President of Product Development
Almac Diagnostic Services

Kenneth Bloom

Head of Pathology
Nucleai

Kimberly Wilber

Director – R&D
Abbott

Lauren Silvis

Senior Vice President of External Affairs
Tempus AI

Leila Luheshi

Vice President, Pharma Partnering
OGT, a Sysmex Group Company

Maria Szwarc

Scientist I
Flagship Biosciences

Mark Venghaus

Senior Director of CDx
Akoya Biosciences

Martin Guillet

Matt Leavitt

Executive Director, The DDx Foundation, Founder & Chairman
Lumea

Meriem Sefta

Chief Diagnostics Officer
OWKIN FRANCE

Micah Schloss

Director, CDx Regulatory Affairs
Agilent Technologies

Michael Yasiejko

Executive Vice President & General Manager, Genomics
Tempus AI

Murtaza Mehdi

Senior Director, Business Development
Agilent Technologies

Pahini Pandya

Founder & Chief Executive Officer
Panakeia Technologies

Pavan Anne

Partner & Precision Medicine Practice Lead
ZS

Pierre Moulin

Chief Scientific Officer
Diagnexia Analytix

Samuel Mathew

Director –Regulatory Affairs
Abbott

Scott Reid

Vice President & Global Head of Companion Diagnostics
Discovery Life Sciences

Seamus Kearney

Chief Executive Officer
ARC Regulatory

Siraj Ali

Senior Business Development Director
Lunit

Stephane Mouradian

Senior Vice President - Business Development
Personalis Inc

Tom Grogan

Professor Emeritus, Pathologist, and Founder of Ventana Medical Systems
Roche

Varun Pattani

Vice President, Precision Medicine Solutions
Foundation Medicine

Verena Aumiller

Vice President - Scientific Programs
Aignostics

Yanchen Li

Senior Director, Pharmaceutical Collaboration
Genetron Health

Yelina Noskina

Senior Manager, Global Scientific Affairs – Oncology & CDx
Abbott

Yiming Guo

Scientist, Translational Medicine
Burning Rock Biotech

Yuri Fesko

Chief Medical Officer
Quest Diagnostic

Explore the New Agenda

Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients

View the Presentation & Speaker Line-Up

Prioritize Partnering with Us

Take up a partnering slot to stand alongside leading biomarker, diagnostic and technology providers, ensure your brand is front and center, and retain your position as the partner of choice in the ever-expanding precision medicine space

View Partnership Options

Join 850+ Specialist Experts

Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations